Conversely, abnormal glucose metabolism (such as mutations in key enzyme genes) can also lead to malignant tumors.1, 2 Isocitrate dehydrogenase (IDH) is the rate‐limiting enzyme in the Krebs cycle that catalyzes oxidative decarboxylation of isocitrate to α‐ketoglutaric acid. This evidence concerns the gene IDH1 and cancer.